Summary
Several factors must be taken into consideration in order to establish whether or not 6-hydroxydopamine (6-OHDA) introduced in the CNS more or less selectively destroys monoaminergic and, more especially, catecholaminergic structures. These include an assessment of all elements possibly damaged following different sites of injection in various species, a comparison with the effects of known neurotoxic agents, the degree of diffusion and/or of dilution of the substance used, the assessment of associated behavioral, neurochemical and morphological changes in the light of the known topography of brain nervous structures etc. A comparison of the effects of 6-OHDA and of peroxide (H2O2) introduced in the CNS suggests that both agents produced similar morphological changes in various sites of the brains of cats and rats. In the light of various data in the literature and of the results reported in this study it appears that 6-OHDA which may be used to induce a focal lesion cannot be regarded as a specific neurotoxic agent.
Similar content being viewed by others
References
Agid, Y., Javoy, F., Glowinski, J., Bovet, D., Sotelo, C.: Injections of 6-hydroxydopamine into the substantia nigra of the rat. II. Diffusion and specificity. Brain Res.58, 291–301 (1973).
Aunis, D., Miras-Portugal, M. T., Mandel, P.: Inhibition of adrenal Dopamine-B-hydroxylase by 6-hydroxydopamine. Biochem. Pharmacol.22, 2581–2589 (1973).
Breese, G. R., Traylor, T. D.: Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: effects of 6-hydroxydopamine. Br. J. Pharmacol.44, 210–222 (1972).
Butcher, L. L., Eastgate, S. M., Hodge, G. K.: Evidence that punctate intracerebral administration of 6-hydroxydopamine fails to produce selective neuronal degeneration: Comparison with copper sulfate and factors governing the department of fluids injected into brain. Naunyn-Schmiedeberg's Arch. Pharmacol.285, 31–70 (1974).
Cohen, G., Hochstein, P.: Glutathione peroxidase: the primary agent for the elemination of hydrogen peroxide in erythrocytes. Biochem.2, 1420 to 1428 (1963).
Fibiger, H. C., Lonsbury, B., Cooper, H. P.: Early behavioural effects of intraventricular administration of 6-hydroxydopamine in rat. Nature New Biology236, 209–211 (1972 a).
Fibiger, H.C., Pudritz, R.E., McGeer, P.L., McGeer, E.G.: Axonal transport in nigro-striatal and nigro-thalamic neurons: effects of medial forebrain bundle lesions and 6-hydroxydopamine. J. Neurochem.19, 1697–1708 (1972 b).
Flohe, L., Brand, I.: Kinetics of glutathione peroxidase. Biochim. biophys. Acta191, 541–549 (1969).
Heikkila, R., Cohen, G.: Inhibition of biogenic amine uptake by hydrogen peroxide: A mechanism for toxic effects of 6-hydroxydopamine. Science172, 1257–1258 (1971).
Heikkila, R., Cohen, G.: Further studies on the generation of hydrogen peroxide by 6-OHDA. Molecular Pharmacol.8, 241–248 (1972).
Heikkila, R., Cohen, G.: 6-Hydroxydopamine: Evidence for Superoxide radical as an oxidative intermediate. Science181, 456–458 (1973).
Kaplanski, J., Nyakas, C., van Delft, A. M. L., Smelik, P. G.: Effect of central early postnatal 6-hydroxydopamine administration on brain catecholamines and pituitary-adrenal function in adulthood. Neuroendocrinology13, 123–217 (1973/74).
Malmfors, T., Sachs, Ch.: Degeneration of adrenergic nerves produced by 6-hydroxydopamine. Europ. J. Pharmacol.3, 89–92 (1968).
Poirier, L. J., Langelier, P., Roberge, A. G., Boucher, R., Kitsikis, A.: Nonspecific histopathological changes induced by the intracerebral injection of 6-hydroxydopamine (6-OHDA). J. neurol. Sci.16, 401–416 (1972).
Roberge, A. G., Poirier, L. J.: Brain Dopa/5-HTP decarboxylase activity after the chronic administration of L-Dopa or 5-hydroxy-L-tryptophan in normal and lesioned cats. Brain Res.76, 401–412 (1974).
Smith, R. D., Barrett, R., Breese, G. R.: Growth and behavioral changes in developing rats treated intracisternally with 6-hydroxydopamine: evidence for involvement of brain dopamme. J. Pharmacol. exp. Ther.185, 609–619 (1973).
Sotelo, C., Javoy, F., Agid, Y., Glowinski, J.: Injection of 6-hydroxydopamine in the substantia nigra of the rat. I. Morphology study. Brain Res.58, 269–290 (1973).
Tranzer, J. P., Thoenen, H.: Ultramorphologische Veränderungen der sympathischen Nervendigungen der Katze nach Vorbehandlung mit 5- und 6-Hydroxydopamine. Arch. Pharmakol, exptl. Path.257, 343–344 (1967).
Tranzer, J. P., Thoenen, H.: An electron microscopic study of selective, acute degeneration of sympathetic nerve terminals after administration of 6-hydroxydopamine. Experientia24, 155–156 (1968).
Ungerstedt, U.: 6-Hydroxydopamine-induced degeneration of central monoamine neurons. Europ. J. Pharmacol.5, 107–110 (1968).
Ungerstedt, U.: Histochemical studies on the effect of intracerebral and intraventricular injections of 6-hydroxydopamine on monoamine neurons in the rat brain. In: 6-Hydroxydopamme lesions of the nigrostriatal dopamine system (Malmfors, T., Thoenen, H., eds.), pp. 101 to 127. Amsterdam: North-Holland. 1971.
Ungerstedt, U., Arbuthnott, G.: Quantitative recording of rotational behaviour in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system. Brain Res.24, 485–493 (1970).
Uretsky, N. J., Iversen, L. L.: Effects of 6-hydroxydopamine on noradrenaline containing neurons in the rat brain. Nature (London)221, 557–559 (1969).
Uretsky, N. J., Iversen, L. L.: Effects of 6-hydroxydopamine on catechol amine containing neurones in the rat brain. J. Neurochem.17, 269–278 (1970).
Voigtlander, P. F. von, Moore, K. E.: Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-Dopa, amantadine, amphetamine and other psychomotor stimulants. Neuropharmcol.12, 451–462 (1973).
Ziegler, H., Del Basso, P., Longo, V. G.: Influence of 6-hydroxydopamine and ofα-methyl-p-tyrosine on the effects of some centrally acting agents. Physiol. and Behavior.8, 391–396 (1972).
Zigmond, J., Strieker, M.: Deficits in feeding behavior after intraventricular injection of 6-hydroxydopamine in rats. Science177, 1211–1214 (1972).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Poirier, L.J. Histopathological changes associated with the intracerebral injection of 6-hydroxydopamine (6-OHDA) and peroxide (H2O2) in the cat and the rat. J. Neural Transmission 37, 209–218 (1975). https://doi.org/10.1007/BF01670129
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01670129